IDEXX LABORATORIES INC /DE Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- IDEXX LABORATORIES INC /DE share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 451.00K shares, a 92.74% increase from fiscal 2024.
- IDEXX LABORATORIES INC /DE share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 234.00K shares, a 8.84% increase from fiscal 2023.
- IDEXX LABORATORIES INC /DE share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 215.00K shares, a 24.28% increase from fiscal 2022.
- IDEXX LABORATORIES INC /DE share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 173.00K shares, a 44.19% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 451.00K shares 10-K · filed 2026-02-20 | |
| 2024-12-31 | 234.00K shares 10-K · filed 2025-02-21 | |
| 2023-12-31 | 215.00K shares 10-K · filed 2024-02-22 | |
| 2022-12-31 | 173.00K shares 10-K · filed 2023-02-16 | |
| 2021-12-31 | 310.00K shares 10-K · filed 2022-02-16 | |
| 2020-12-31 | 562.00K shares 10-K · filed 2021-02-12 | |
| 2019-12-31 | 445.00K shares 10-K · filed 2020-02-14 | |
| 2018-12-31 | 561.00K shares 10-K · filed 2019-02-15 | |
| 2017-12-31 | 716.00K shares 10-K · filed 2018-02-16 | |
| 2016-12-31 | 838.00K shares 10-K · filed 2017-02-17 | |
| 2015-12-31 | 675.00K shares 10-K · filed 2016-02-17 | |
| 2014-12-31 | 585.00K shares 10-K · filed 2015-02-17 | |
| 2013-12-31 | 837.00K shares 10-K · filed 2014-02-18 | |
| 2012-12-31 | 728.00K shares 10-K · filed 2013-02-19 | |
| 2011-12-31 | 1.04M shares 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |